BioSpace News Archive

Vedanta Biosciences today announced the appointment of Simona Levi, Ph.D., J.D., as Chief Legal Officer and Corporate Secretary.

OnKure, Inc. today announced the appointment of Jennifer R. Diamond, M.D., as Chief Medical Officer.

CytoDyn Inc. today announced that the Delaware Court of Chancery found that CytoDyn’s Board of Directors properly rejected a nomination notice presented by an activist group led by Paul Rosenbaum and Bruce Patterson (the “Rosenbaum/Patterson Group” or the “Activist Group”).

Windtree Therapeutics, Inc. today announced that on Tuesday, October 19, 2021 at 8:00 am Eastern Time it will host a Key Opinion Leader (KOL) webinar on istaroxime for the treatment of acute heart failure and the upcoming data in early cardiogenic shock.

Plus Therapeutics, Inc. announced that the Company will report third quarter 2021 financial results on Thursday, October 21, 2021, after market close.

Reset Pharmaceuticals, Inc. (Reset Pharma) announced today that Stephen Ross, M.D., Chair of Reset Pharma’s Scientific Advisory Board, will deliver a keynote presentation at The End in Mind virtual conference being held on October 14, 2021.

Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2021 financial results on Thursday, October 28, 2021.

OneProjects, developer of four-dimensional (4D) cardiac imaging technology, today announced a total of $17 million in new financing for the company, including an $8 million Series A2 financing and two grants worth $9 million.

Trial is designed to advance pelareorep’s clinical development in China , the world’s second-largest pharmaceutical market

Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of coronaviruses, influenza, hepatitis C viruses and noroviruses, announces that management will present at the Dawson James 2021 Small Cap Growth Conference.